Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nora Asper
Observed names:
N. Asper,
N., Asper
Institution:
University of Zurich
Observed institutions:
University of Zurich,
University Hospital Zurich
ORCID:
0009-0003-7060-3333
Observed ORCID:
0009-0003-7060-3333
OpenAlex ID:
A5093368522
Metastatic Salivary Duct Carcinoma with ERBB2 Amplification and Sequential Response to Ado-Trastuzumab Emtansine and Neratinib: A Case Report
2023
·
Nora Asper
, Kersten Sven Roth
, et al.
·
Case Reports in Oncology
·
5
Using Machine Learning Approaches on Dynamic Patient-Reported Outcomes to Cluster Cancer Treatment-Related Symptoms
2025
·
Nora Asper
, Hans Friedrich Witschel
, et al.
·
Current Oncology
·
3
PDF
Abstract P2-04-21: Dynamic reporting of treatment related symptoms via ePROs can reversely identify the type of underlying cancer
2025
·
Andreas Trojan
, Hans-Friedrich Witschel
, et al.
·
Clinical Cancer Research
1839P Dynamic reporting of treatment related symptoms via ePROs can reversely identify the type of underlying cancer
2024
·
A. Trojan
, H-F. Witschel
, et al.
·
Annals of Oncology
PDF
Supplementary Material for: Metastatic Salivary Duct Carcinoma with ERBB2 Amplification and Sequential Response to Ado-Trastuzumab Emtansine and Neratinib: A case report
2023
·
N., Asper
, K.S., Roth
, et al.
·
Figshare
Show more works
View as search
Works count:
5
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type